Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Colorado State University
Cancer Research UK
Carevive Systems, Inc.
Essen Biotech
Azienda Ospedaliero-Universitaria di Parma
Royal Marsden NHS Foundation Trust
University of Nebraska
Adela, Inc
Mayo Clinic
University Health Network, Toronto
Cancer Research UK
Incyte Corporation
University of Alabama at Birmingham
Baxter Healthcare Corporation
Compugen Ltd
University of Alberta
Universidade Federal de Pernambuco
Cyteir Therapeutics, Inc.
Taproot Health
Sanguine Biosciences
Cancer Support Community, Research and Training Institute, Philadelphia
Gilead Sciences
Scripps Health
Weprom
Celgene
Shenzhen BinDeBio Ltd.
Vanderbilt-Ingram Cancer Center
CureOne
Masonic Cancer Center, University of Minnesota
Amgen
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
Ohio State University Comprehensive Cancer Center
SPGO Research Mannheim GmbH
Rutgers, The State University of New Jersey
Shenzhen Second People's Hospital
Celldex Therapeutics
Barbara Ann Karmanos Cancer Institute
AHS Cancer Control Alberta
Sandoz
Indiana University
National Cancer Institute (NCI)
University of Kentucky
National Cancer Institute (NCI)
Vanderbilt-Ingram Cancer Center
UNC Lineberger Comprehensive Cancer Center
National Institutes of Health Clinical Center (CC)